Tighter regulatory control over cough syrups brings drug quality concerns back into focus
The Indian government has amended the Drugs Rules, 1945, to remove exemptions that allowed the sale of cough syrups in small villages without a license. This move aims to improve regulatory oversight and address quality concerns following international scrutiny.
Why it matters
Strengthening pharmaceutical regulations is essential for public health and restoring international confidence in the quality of Indian-manufactured medicines.
The Union Ministry of Health and Family Welfare recently notified an amendment to the Drugs Rules, 1945. It removed the word “syrups” from Schedule K under the heading ‘Class of Drugs’, thereby withdrawing the exemption for sale of cough syrups in small villages without requiring compliance with certain retail sale licensing provisions.
The article objectively explains the regulatory change and provides context regarding the motivation behind the government's decision.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in